Oxford Biomedica (LSE: OXB) Introduces Fast-Track Viral Vector Manufacturing
Expert Analysis Oxford Biomedica (LSE: OXB) is significantly advancing its cell and gene therapy services by launching a new fast-track offering tailored to viral vector platforms. This strategic move is positioned to streamline the development and accelerate the manufacturing processes for lentiviral and adeno-associated viral vectors, which are critical components in gene therapy applications. The expedited pathway that Oxford Biomedica (LSE: OXB) provides could be transformative for clients, enabling quicker…









